Meletios Dimopoulos, MD, of the Kapodistrian University of Athens School of Medicine, Athens, Greece, discusses some of the challenges facing the management of myeloma patients and highlights the need for novel therapies to myeloma subgroups that have an unmet need. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).